Dow Down 0.71% Nasdaq Down 0.63%

More On SCR

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

(SCR)

-NYSE
0.00 0.00(0.00%) N/A
Prev Close:N/A
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:11.00
Beta:0.16
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:6.90 - 10.90
Volume:0
Avg Vol (3m):730,932
Market Cap:N/A
P/E (ttm):0.00
EPS (ttm):1.24
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in .

Comparison

Symbol% ChgMkt Cap
SCR 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Aug-16) :-0.04
Quarterly EPS Est (Aug-16) :-0.01
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.47

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Simcere Pharmaceutical Group engages in the research, development, manufacture, and distribution of pharmaceutical and vaccine products for pharmaceutical distributors and government in the People’s Republic of China. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback